| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/05/1995 | WO1995000543A1 Anti-inflammatory peptides |
| 01/05/1995 | WO1995000527A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 01/05/1995 | WO1995000514A1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/05/1995 | WO1995000501A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | CA2364039A1 Use of phenyl heterocycles in the relief or treatment of rheumatoid arthritis, osteoarthritis, fever, pain, headache or dysmenorrhea |
| 01/05/1995 | CA2164961A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 01/05/1995 | CA2163888A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/04/1995 | EP0632040A1 Antibacterial imidazole derivatives |
| 01/04/1995 | EP0631503A1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 01/04/1995 | CN1097010A New compound |
| 01/04/1995 | CN1027263C Method for preparation of pyridopyrimidine derivatives |
| 01/03/1995 | US5378720 Treatment of rheumatoid arthritis, emphysema, pancreatitis |
| 01/03/1995 | US5378718 Cardiovascular activity, hypotensive |
| 01/03/1995 | US5378716 Pyrazol-1-yl phenoxyacetic acid compounds which have useful pharmaceutical utility |
| 01/03/1995 | US5378699 Treatment of immune diseases, cell proliferation, restenosis and smooth muscle cells |
| 01/03/1995 | US5378687 Use of human blood coagulation factor XIII for the treatment of ulcerative colitis |
| 01/03/1995 | CA2127318A1 Imidazole compounds and use thereof |
| 01/03/1995 | CA1333803C .alpha.-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters |
| 01/03/1995 | CA1333774C Soft capsular preparation of sodium picosulfate |
| 12/28/1994 | EP0630893A1 N,n'-disubstituted amide derivative |
| 12/28/1994 | EP0630376A1 Condensed indole derivatives as 5ht 4?-receptor antagonists |
| 12/28/1994 | EP0630373A1 Indole derivatives as 5ht1c antagonists |
| 12/28/1994 | EP0630245A1 Protein kinase c inhibitor |
| 12/28/1994 | EP0540526B1 Quinuclidine derivatives |
| 12/28/1994 | CN1027133C Dry adsorbates |
| 12/27/1994 | US5376653 A protease enzyme inhibitor for treating degenerative diseases , respiratory system disorders, rheumatoid arthritis and pancreatitis |
| 12/27/1994 | US5376637 Pharmaceutical preparation containing vasoactive intestinal polypeptide or its analogue |
| 12/27/1994 | US5376636 Method for promoting tissue repair and regeneration using PDGF and glucocorticoids |
| 12/27/1994 | US5376553 Analyzing biological fluid samples for presence of dicitrate cyclic diester which indicates no pathological calcification or predisposition towards it |
| 12/27/1994 | US5376382 Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms of thioctic acid |
| 12/27/1994 | CA1333714C Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis |
| 12/22/1994 | WO1994029336A1 New peptide derivatives |
| 12/22/1994 | WO1994029309A1 Spiro-substituted azacycles as neurokinin antagonists |
| 12/22/1994 | WO1994029304A1 Thienylthiazole derivatives |
| 12/22/1994 | WO1994029298A1 8-amino-7-chloro-1,4-benzodioxan-5-carboxylic acid, -1-butyl-4-piperidinyl ester as a 5-ht4-receptor antagonist |
| 12/22/1994 | WO1994029274A1 New active compounds |
| 12/22/1994 | WO1994029262A1 Lipoxin compounds |
| 12/22/1994 | WO1994028911A1 COMPOSITIONS FOR USE IN THE REGULATION OF SUBNORMAL pH VALUES IN THE INTESTINAL TRACT AND FOR TREATMENT OF BOWEL DISEASES |
| 12/22/1994 | WO1994028910A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 12/22/1994 | WO1994028895A2 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 12/22/1994 | WO1994017773A3 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 12/22/1994 | CA2164875A1 New active compounds |
| 12/22/1994 | CA2164827A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 12/22/1994 | CA2164606A1 Compositions for use in the regulation of subnormal ph values in the intestinal tract and for treatment of bowel diseases |
| 12/22/1994 | CA2163995A1 Spiro-substituted azacycles as neurokinin antagonists |
| 12/22/1994 | CA2140660A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 12/21/1994 | EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them |
| 12/21/1994 | EP0629393A2 A crystalline polyol composition |
| 12/21/1994 | EP0629199A1 Indole derivatives as 5-ht1 agonists |
| 12/21/1994 | EP0629132A1 PURIFIED VACUOLATING TOXIN FROM $i(HELICOBACTER) PYLORI AND METHODS TO USE SAME |
| 12/21/1994 | CN1027068C Alpha-substituted 4-(quinolin-2-yl-methoxy)-phenylacetic acide and-esters |
| 12/20/1994 | US5374772 Substituted benzoic acids, inhibitors of phospholipases A2 |
| 12/20/1994 | US5374730 Oxidation of substituted pyridine-benzimidazole sulfides to form amide sulfinyl compounds, then alkaline hydrolysis to form sulfinyl carboxylates and decarboxylation |
| 12/20/1994 | US5374656 N-phenyl-n-alkoxycarbonylalkyl glycinamides, their preparation and the medicaments containing them |
| 12/20/1994 | US5374640 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides |
| 12/20/1994 | US5374637 N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
| 12/20/1994 | US5374623 Cysteine protease inhibitors effective for in vivo use |
| 12/20/1994 | CA1333647C Heptapeptide analogs of somatostatin |
| 12/18/1994 | CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them |
| 12/14/1994 | EP0628302A2 Oral composition containing salicylanilide antibacterial agent |
| 12/14/1994 | EP0628049A1 Substituted benzimidazoles, process for their preparation as well as their use |
| 12/14/1994 | EP0628043A1 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist |
| 12/14/1994 | EP0628042A1 Serotoninergic ergoline derivatives |
| 12/14/1994 | EP0628033A1 Benzodiazepin derivatives useful as cck-receptor antagonists |
| 12/14/1994 | EP0628032A1 Quinazolinone antianginal agents |
| 12/14/1994 | EP0627927A1 Use of injectable biomaterials in the treatment of hemorrhoids |
| 12/14/1994 | EP0627925A1 Trypsin inhibitors |
| 12/14/1994 | EP0627900A1 Use of injectable biomaterials for the repair and augmentation of the anal sphincters |
| 12/14/1994 | EP0565558B1 Process and intermediates for preparing azabicyclo 2.2.2]octan-3-imines |
| 12/14/1994 | EP0558475B1 Method and composition for controlled delivery of biologically active agents |
| 12/14/1994 | EP0498830B1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation |
| 12/14/1994 | EP0382840B1 Aloe compositions and uses thereof |
| 12/13/1994 | US5373024 3,5-Substituted benzoylguanidines, process for their preparation, their use as a medicament of diagnostic and medicament containing them |
| 12/13/1994 | CA2067758C Piperidine and pyrrolidine derivatives |
| 12/12/1994 | CA2125542A1 Oral composition containing salicylanilide antibacterial agent |
| 12/11/1994 | CA2508477A1 Method of preventing emesis and treating sexual dysfunction using tetrahydrobenz ¬cd| indole-6-carboxamides |
| 12/11/1994 | CA2125088A1 Method of preventing emesis and treating sexual dysfunction using tetrahydrobenz ¬cd| indole-6-carboxamides |
| 12/08/1994 | WO1994028132A2 Opioid receptors: compositions and methods |
| 12/08/1994 | WO1994027998A1 Psoralen®* derivatives, their preparation and use |
| 12/08/1994 | WO1994027994A1 Piperidine derivatives, their preparation and use |
| 12/08/1994 | WO1994027988A1 Optically pure salts of pyridinylmethyl sulfinyl-ih-benzimidazole compounds |
| 12/08/1994 | WO1994027979A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 12/08/1994 | WO1994027965A1 Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 12/08/1994 | WO1994027623A1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 12/08/1994 | WO1994027616A1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 12/08/1994 | WO1994027599A1 Rectal compositions |
| 12/08/1994 | WO1994027577A1 Liquid antacid compositions |
| 12/08/1994 | WO1994016096A3 Method to predict active growth of bacteria adhered to a surface |
| 12/08/1994 | CA2337581A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds and intermediates in the preparation therefor |
| 12/08/1994 | CA2163737A1 Anti-cholesterolemic egg, vaccine and method for production and use |
| 12/08/1994 | CA2163350A1 Opioid receptors: compositions and methods |
| 12/07/1994 | EP0627407A1 (7S)-7-(2(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them |
| 12/07/1994 | EP0627221A2 Substance P antagonists for the treatment of emesis |
| 12/07/1994 | EP0626973A1 Phenylalanine analogs of bombesin |
| 12/07/1994 | EP0626969A1 CoA-IT AND PAF INHIBITORS |
| 12/06/1994 | US5371097 Antiulcer agents |
| 12/06/1994 | US5370991 Cloned gene encoding human monocyte elastase inhibitor |
| 12/06/1994 | CA2005072C Antispasmodic agent comprising creosote or its phenol derivative |
| 11/30/1994 | EP0626378A1 Saccharin derivative proteolytic enzyme inhibitors |
| 11/30/1994 | EP0626367A1 (7S)-7-(1R)-2-(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydronaphtalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them |